Literature DB >> 30329031

Atrial fibrillation hospitalization, mortality, and therapy.

Roy M John1, Gregory F Michaud1, William G Stevenson1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30329031     DOI： 10.1093/eurheartj/ehy622

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  7 in total

1.  Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status.

Authors:  Josep Redon; Maria Jose Forner; Jose Miguel Calderon; Fernando Martinez; Antonio Fernandez; Inmaculada Sauri; Javier Diaz; Ruth Uso; Jose Luis Trillo
Journal:  Sci Rep       Date:  2022-04-12       Impact factor: 4.379

2.  Low alanine aminotransferase levels are independently associated with mortality risk in patients with atrial fibrillation.

Authors:  Yuki Saito; Yasuo Okumura; Koichi Nagashima; Daisuke Fukamachi; Katsuaki Yokoyama; Naoya Matsumoto; Eizo Tachibana; Keiichiro Kuronuma; Koji Oiwa; Michiaki Matsumoto; Toshihiko Nishida; Toshiaki Kojima; Shoji Hanada; Kazumiki Nomoto; Kazumasa Sonoda; Ken Arima; Fumiyuki Takahashi; Tomobumi Kotani; Kimie Ohkubo; Seiji Fukushima; Satoru Itou; Kunio Kondo; Hideyuki Ando; Yasumi Ohno; Motoyuki Onikura; Atsushi Hirayama
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

3.  Pinocembrin Decreases Atrial Fibrillation Susceptibility in a Rodent Model of Depression.

Authors:  Qian Ran; Xiaoli Chen; Cui Zhang; Weiguo Wan; Tianxin Ye; Yazhou Sun; Xin Zhao; Shaobo Shi; Bo Yang; Qingyan Zhao
Journal:  Front Cardiovasc Med       Date:  2022-05-20

4.  Comprehensive assessment of left atrial and ventricular remodeling in paroxysmal atrial fibrillation by the cardiovascular magnetic resonance myocardial extracellular volume fraction and feature tracking strain.

Authors:  Akimasa Yamada; Naoki Hashimoto; Hidesato Fujito; Takumi Hatta; Yuki Saito; Naoto Otsuka; Yuji Wakamatsu; Masaru Arai; Ryuta Watanabe; Sayaka Kurokawa; Daisuke Kitano; Koichi Nagashima; Shunichi Yoda; Yasuo Okumura
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

5.  Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women

Authors:  Humberto Rodríguez-Reyes; César I Laguna-Muñoz; Carlos F Gallegos-de Luna; Manuel O de-Los-Ríos-Ibarra; José L Salas-Pacheco; José L Leyva-Pons; Luz M Muñoz-Gutiérrez; Arturo Vargas-Hernandez; Karla M Rodríguez-Muñoz; Jaime Barragán-Luna; Marco A Alcocer-Gamba; Jorge Cortez-Lawrenz; Julio Farjat-Ruiz
Journal:  Arch Cardiol Mex       Date:  2022-07-01

6.  Overexpression of miR-27b-3p Targeting Wnt3a Regulates the Signaling Pathway of Wnt/β-Catenin and Attenuates Atrial Fibrosis in Rats with Atrial Fibrillation.

Authors:  Xiangwei Lv; Jinyi Li; Yisen Hu; Shirong Wang; Chengye Yang; Chengxuan Li; Guoqiang Zhong
Journal:  Oxid Med Cell Longev       Date:  2019-04-17       Impact factor: 6.543

7.  Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation.

Authors:  Jose Miguel Calderon; Fernando Martinez; Javier Diaz; Antonio Fernandez; Inmaculada Sauri; Ruth Uso; Jose Luis Trillo; Sara Vela; Carlos Bea; Josep Redon; Maria Jose Forner
Journal:  Front Cardiovasc Med       Date:  2022-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.